CareDx Accuses Natera of False Advertising in Second Lawsuit

Apr 10, 2019

|

This article has been updated to include a statement from Natera.

NEW YORK (GenomeWeb) – CareDx has filed a second lawsuit against Natera today in the United States District Court for Delaware, accusing the company of trying to "mislead" patients and clinicians into thinking that Natera's Prospera kidney transplant test is superior to CareDx's AlloSure organ transplant diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Maybe Not to Eat…

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Moving From DC to KC

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Just for Fun?

Slate's Jane Hu compares some at-home genetic tests to astrology.

PLOS Has Skin Cancer Risk Scores and More This Week

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.

Menu